Just in Time Release of CAR T Cell Therapies During Covid-19

29th November 2021 | 10:00am EST | Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux |WATCH FOR FREE

Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb

Irving is currently the Site QA Head at BMS’ multi-product CAR T facility. Irving has over 28 years of QA/QC experience in the pharmaceutical/biotechnology and cell/gene therapies industries. Prior to joining BMS, Irving was a significant contributor to activities supporting the commercial approval of Novartis’ CAR T product Kymriah.  Since then Irving successfully supported activities for the commercial approval of BMS’ CAR T product Abecma. Irving is an active member of PDA and has served on several planning committees for various PDA Conferences.  Irving is a co-author of PDA TR-13- EM of Low Bioburden Facilities and for the published White Paper – Risk Assessment Approach to Microbiological Controls of Cellular Therapies. Irving is currently co-authoring a PDA ATMP Points to Consider document.
Followed by Lori Daane, Pharma Microbiology Scientific Director at bioMérieux

Lori Daane is the Director of Scientific Affairs at bioMérieux and has over 30 years of experience in clinical, environmental, and industrial microbiology.  She is a technical expert on rapid and alternative methods and provides scientific support to the Healthcare Business in North America. Prior to joining bioMérieux, Lori worked for 11 years at Celsis in a variety of technical roles including VP of Scientific Affairs and Reagent Development.   Lori received her Ph.D. from the University of Minnesota in Microbial Ecology and performed postdoctoral research at Rutgers University and Los Alamos National Laboratory. She also holds a Master’s degree in Limnology and a Bachelor’s degree in Medical Technology.
Sponsored by BioMérieux

With more than 50 years of pioneering diagnostics, the people of bioMérieux understand the challenges you face when it comes to ensuring product quality and are proud to offer the most comprehensive portfolio of solutions for microbiology Quality Control of biopharmaceuticals and ATMPs.  Choosing the right microbiology diagnostic can boost efficiency with in-processes testing and automation simplifies the testing processes, reduces human error, and helps ensures data integrity. Rapid, simple, at-line testing of key parameters allows in-process tests to be performed closer to the production environment and provides certainty that your manufacturing process is secure.

We will not sell your information to a third party. See our Privacy Policy

Biopharma Webinars